Examples of Bausch & Lomb in a sentence
In addition, prior to the consummation of the Bausch & Lomb Acquisition, Bausch & Lomb Escrow Issuer shall not be deemed a Subsidiary for purposes of this Agreement or any other Credit Document, and, for the avoidance of doubt, shall not be subject to the (i) requirements of Section 5 (including, for the avoidance of doubt, Section 5.10) or Section 6 hereof, (ii) representations and warranties in Section 4 hereof or (iii) Events of Default in Section 8 hereof.
If debris is present, always use a new (not previously opened) Bausch & Lomb Pre-Moistened Tissue to clean the window.
Bausch + Lomb has a broad portfolio of eye health products, including well-known prescription and OTC brands Besivance, Lotemax, Ocuvite and PreserVision; vision care brands Biotrue ONEday, PureVision, xxxx and Boston; and surgical brands enVista, Storz, Stellaris and VICTUS.
The Lenders, the Issuing Bank and their respective Affiliates hereby agree that none of the Administrative Agent, the Collateral Agent or any Affiliate thereof shall have any liability or obligation to the Lenders, in their capacities as such, with respect to any transactions contemplated by the Bausch & Lomb New Senior Notes Documents.
Bausch + Lomb expects to have revenues of approximately $3.3 billion and adjusted EBITDA in 2013 of approximately $720 million.
Bausch & Lomb Surgical, Fr., No. 19760-NC, 2004 WL 5366102, at *7 (Del.
XxXxxxx Title: Treasurer ISTA PHARMACEUTICALS, LLC By: Bausch & Lomb Pharma Holdings Corporation, its member By: /s/ Xxxxx X.
The Investment Committee shall be the Investment Committee of Bausch & Lomb Incorporated.
There can also be no assurance that cash flows generated by Nicox will be sufficient to pay the bonds at their maturity which could have a material adverse effect on its business, with security interests having been granted over certain tangible and intangible assets of Nicox S.A., and notably patents relating to the approved product VYZULTA (with the pledge having no impact on the exclusive worldwide license agreement with Bausch + Lomb), securities of the subsidiary Nicox Ophthalmics Inc.
Bausch + Lomb will retain its name and become a division of Valeant.